Omalizumab is as Effective as Multi-Food Oral Immunotherapy for Allergenic Food Tolerability
PR Newswire —
More than 60% of participant dietary consumption plans showed no significant difference between omalizumab and multi-food oral immunotherapy success rates after 12 months MILWAUKEE, Feb. 22, 2026 /PRNewswire/ -- There is no significant difference between the successful consumption of...